Want to see ACAN full AI Analyst Report?
AmeriCann (ACAN) Price & Analysis
ACAN Stock Chart & Stats
- Day’s Range
- $0.02 - $0.02
- 52-Week Range
- $0.01 - $0.09
- Previous Close
- $0.02
- Volume
- 3,700
- Average Volume (3M)
- 64.18K
- Market Cap
- $2,439
- Enterprise Value
- $9.24T
- Total Cash (Recent Filing)
- $131.16K
- Total Debt (Recent Filing)
- $6.79M
- Price to Earnings (P/E)
- ―
- Beta
- 15.21
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Sustainable Practices
AmeriCann's focus on sustainable practices in cannabis cultivation positions it well in an industry increasingly valuing environmental responsibility, potentially attracting eco-conscious tenants and partners.
Strategic Partnerships
Strategic partnerships and additional services like consulting and facility management can enhance tenant operations, increase revenue streams, and strengthen AmeriCann's market position.
High Gross Profit Margin
A high gross profit margin indicates strong pricing power and operational efficiency at the core level, providing a foundation for potential profitability improvements if operational inefficiencies are addressed.
Bears Say
Negative Cash Flows
Negative cash flows suggest operational inefficiencies and potential liquidity issues, which can impede the company's ability to fund operations and invest in future growth.
High Leverage
High leverage increases financial risk, potentially limiting the company's ability to invest in growth opportunities and weather economic downturns, impacting long-term sustainability.
Declining Revenue
Declining revenue trends undermine financial stability and growth prospects, indicating challenges in maintaining market share and competitiveness in the cannabis industry.
AmeriCann News
ACAN FAQ
What was AmeriCann’s price range in the past 12 months?
What is AmeriCann’s market cap?
When is AmeriCann’s upcoming earnings report date?
How were AmeriCann’s earnings last quarter?
Is AmeriCann overvalued?
Does AmeriCann pay dividends?
What is AmeriCann’s EPS estimate?
How many shares outstanding does AmeriCann have?
What happened to AmeriCann’s price movement after its last earnings report?
Which hedge fund is a major shareholder of AmeriCann?
What is the TipRanks Smart Score and how is it calculated?
Company Description
AmeriCann
AmeriCann, Inc., with its headquarters in Denver, Colorado, functions as a specialized cannabis enterprise throughout the United States. The company offers a complete range of services to authorized cannabis businesses, handling the conception, construction, leasing, and daily management of facilities crucial for cultivating, processing, and manufacturing cannabis products. A significant venture for the firm is the Massachusetts Cannabis Center, an extensive development located on a 52-acre property in Freetown, southeastern Massachusetts. Furthermore, AmeriCann supplies cannabis for both medical applications and adult recreational consumption. Incorporated in 2010, the organization initially operated as Nevada Health Scan, Inc., eventually rebranding to AmeriCann, Inc. in 2014.
- Sector
- Realestate
- Industry
- Real Estate - Development
- CEO
- Timothy Ryan Keogh
- Employees
- 3
- Website
- www.americann.co
- Address
- 1555 Blake Street, Denver, CO, 80202, US

